Archive for Profitability

Using the Brand Comparisons data form the Profitability section of the Dispex website, we will be publishing Dispensary Friendly formularies for a number of conditions, starting with Adult Asthma. There...

Click here to login and view. ​

Using the Brand Comparisons data from the Dispex website, we will be publishing dispensary friendly formularies for a number of conditions. Members can login here to see the COPD section.

Dispensary Friendly Formulary – another resource to help Dispex members By Dr Philip Koopowitz – Dispex & Hexagon6 Dispex has a wealth of resources to assist practices in creating their...

Using the Brand Comparisons data form the Profitability section of the Dispex website, we will be publishing Dispensary Friendly formularies for a number of conditions, starting with Adult Asthma. There...

 UPDATE from Dispex 25th October 2024 By Dr Philip Koopowitz – Dispex & Hexagon6 Following clarification from NHSBSA, the reclassification of Nexplanon as “Attracts an Administration Fee” only comes into...

By Dr Philip Koopowitz – Dispex & Hexagon6 The Dispensing Fee Scale from 1st October 2024 has been published and will impose a miniscule reduction in the Dispensing Fees. This...

The DHSC has published an updated Category M price list starting on 1 August and continuing until the end of September. According to the NHSBSA Prescription Services website: “Due to...